Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOSE: Corticosteroid Dosing in COPD Exacerbations
NCT01742338Phase 4Terminated
- Sponsor
- Rutgers University
- Start
- May 2012
- Primary completion
- Mar 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methylprednisolone in chronic obstructive pulmonary disease (COPD), sponsored by Rutgers University. Started May 2012; status: terminated.
02
Drugs
methylprednisolone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01742338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01742338.